VCIM
PMVP icon

Velan Capital Investment Management’s PMV Pharmaceuticals PMVP Stock Holding History

Velan Capital Investment Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90.5K Buy
73,000
+38,000
+109% +$48.3K 0.06% 45
2025
Q4 		$43.8K Hold
35,000
– – 0.03% 46
2025
Q3 		$49K Hold
35,000
– – 0.05% 49
2025
Q2 		$37.1K Hold
35,000
– – 0.04% 49
2025
Q1 		$38.1K Hold
35,000
– – 0.04% 43
2024
Q4 		$52.9K Buy
+35,000
New +$55.4K 0.05% 37

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Velan Capital Investment Management's PMVP Position: Q1 2026 in Review

Velan Capital Investment Management increased its PMV Pharmaceuticals (PMVP) stake by 109% in Q1 2026, buying an estimated $48.3K and bringing the position to 73,000 shares worth $90.5K. The position accounts for 0.06% of the portfolio, ranked #45.

Velan Capital Investment Management first reported a position in PMVP in Q4 2024 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Velan Capital Investment Management held 73,000 shares of PMV Pharmaceuticals worth $90.5K as of Q1 2026.
  • Velan Capital Investment Management bought 38,000 PMV Pharmaceuticals shares in Q1 2026, an estimated $48.3K.
  • PMV Pharmaceuticals made up 0.06% of Velan Capital Investment Management's portfolio in Q1 2026, its #45 holding.
  • Velan Capital Investment Management first reported a position in PMV Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.